Last reviewed · How we verify
Advanced Medical Therapy
Advanced Medical Therapy works by modulating the immune system to treat various conditions.
Advanced Medical Therapy works by modulating the immune system to treat various conditions. Used for Multiple sclerosis, Rheumatoid arthritis.
At a glance
| Generic name | Advanced Medical Therapy |
|---|---|
| Sponsor | Hadassah Medical Organization |
| Drug class | Immunomodulator |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Mechanism of action
It does this by enhancing the body's natural immune response to fight diseases. This is achieved through a complex interplay of immune cells and signaling pathways.
Approved indications
- Multiple sclerosis
- Rheumatoid arthritis
Common side effects
- Increased risk of infections
- Fatigue
- Headache
Key clinical trials
- Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (PHASE1)
- Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations (PHASE2)
- Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors (PHASE2)
- Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial (PHASE2, PHASE3)
- Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer (PHASE3)
- Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma (PHASE1, PHASE2)
- Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones (PHASE2)
- Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Advanced Medical Therapy CI brief — competitive landscape report
- Advanced Medical Therapy updates RSS · CI watch RSS
- Hadassah Medical Organization portfolio CI